Is Sight Sciences Stock a Good Investment?
Sight Sciences Investment Advice | SGHT |
- Examine Sight Sciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Sight Sciences' leadership team and their track record. Good management can help Sight Sciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Sight Sciences' business and its evolving consumer preferences.
- Compare Sight Sciences' performance and market position to its competitors. Analyze how Sight Sciences is positioned in terms of product offerings, innovation, and market share.
- Check if Sight Sciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Sight Sciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Sight Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Sight Sciences is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Sight Sciences Stock
Researching Sight Sciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 20.0% of the company outstanding shares are owned by corporate insiders. The book value of Sight Sciences was at this time reported as 1.88. The company recorded a loss per share of 1.01. Sight Sciences had not issued any dividends in recent years.
To determine if Sight Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sight Sciences' research are outlined below:
| Sight Sciences generated a negative expected return over the last 90 days | |
| Sight Sciences has high historical volatility and very poor performance | |
| Sight Sciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 81.06 M. Net Loss for the year was (55.55 M) with profit before overhead, payroll, taxes, and interest of 58.97 M. | |
| Sight Sciences currently holds about 220.1 M in cash with (47.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Sight Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 2891 shares by Jesse Selnick of Sight Sciences at 12.379 subject to Rule 16b-3 |
Sight Sciences Quarterly Cost Of Revenue |
|
Sight Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sight Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sight Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Sight Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Sight Sciences' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-03 | 2023-06-30 | -0.34 | -0.3 | 0.04 | 11 | ||
2023-05-04 | 2023-03-31 | -0.39 | -0.35 | 0.04 | 10 | ||
2024-08-01 | 2024-06-30 | -0.3 | -0.25 | 0.05 | 16 | ||
2024-05-02 | 2024-03-31 | -0.28 | -0.33 | -0.05 | 17 | ||
2023-11-07 | 2023-09-30 | -0.32 | -0.27 | 0.05 | 15 | ||
2022-03-24 | 2021-12-31 | -0.39 | -0.34 | 0.05 | 12 | ||
2021-11-10 | 2021-09-30 | -0.37 | -0.43 | -0.06 | 16 | ||
2023-03-13 | 2022-12-31 | -0.42 | -0.35 | 0.07 | 16 |
Know Sight Sciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sight Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sight Sciences backward and forwards among themselves. Sight Sciences' institutional investor refers to the entity that pools money to purchase Sight Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 325.8 K | D. E. Shaw & Co Lp | 2024-09-30 | 321.6 K | Millennium Management Llc | 2024-06-30 | 296.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 257 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 207.9 K | Panagora Asset Management Inc | 2024-09-30 | 194.8 K | National Asset Management Inc | 2024-06-30 | 185.1 K | Millrace Asset Group, Inc | 2024-09-30 | 138.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 136 K | Bank Of America Corp | 2024-06-30 | 3.1 M | Ubs Group Ag | 2024-06-30 | 2.9 M |
Sight Sciences' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 197.06 M.Market Cap |
|
Sight Sciences' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.37) | (0.39) | |
| Return On Assets | (0.33) | (0.35) | |
| Return On Equity | (0.46) | (0.44) |
Determining Sight Sciences' profitability involves analyzing its financial statements and using various financial metrics to determine if Sight Sciences is a good buy. For example, gross profit margin measures Sight Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sight Sciences' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Sight Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sight Sciences. Check Sight Sciences' Beneish M Score to see the likelihood of Sight Sciences' management manipulating its earnings.
Evaluate Sight Sciences' management efficiency
Sight Sciences has return on total asset (ROA) of (0.1941) % which means that it has lost $0.1941 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4536) %, meaning that it created substantial loss on money invested by shareholders. Sight Sciences' management efficiency ratios could be used to measure how well Sight Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.35 in 2024. Return On Capital Employed is likely to drop to -0.39 in 2024. At this time, Sight Sciences' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 4.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 11.6 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.47 | 2.60 | |
| Tangible Book Value Per Share | 2.47 | 2.60 | |
| Enterprise Value Over EBITDA | (3.00) | (3.15) | |
| Price Book Value Ratio | 2.09 | 2.19 | |
| Enterprise Value Multiple | (3.00) | (3.15) | |
| Price Fair Value | 2.09 | 2.19 | |
| Enterprise Value | 148.2 M | 140.8 M |
Examining the leadership quality of Sight Sciences offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Beta 2.734 |
Basic technical analysis of Sight Stock
As of the 30th of November, Sight Sciences has the Risk Adjusted Performance of (0.13), coefficient of variation of (565.08), and Variance of 15.97. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sight Sciences, as well as the relationship between them.Sight Sciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sight Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sight Sciences' Outstanding Corporate Bonds
Sight Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sight Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sight bonds can be classified according to their maturity, which is the date when Sight Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| SIERRA 6 15 JUN 28 Corp BondUS82653LAA98 | View |
Understand Sight Sciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Sight Sciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 3.0 | |||
| Coefficient Of Variation | (565.08) | |||
| Standard Deviation | 4.0 | |||
| Variance | 15.97 | |||
| Information Ratio | (0.21) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 18.22 | |||
| Value At Risk | (7.84) | |||
| Potential Upside | 6.65 | |||
| Skewness | (0.06) | |||
| Kurtosis | 0.4017 |
| Risk Adjusted Performance | (0.13) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 3.0 | |||
| Coefficient Of Variation | (565.08) | |||
| Standard Deviation | 4.0 | |||
| Variance | 15.97 | |||
| Information Ratio | (0.21) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 18.22 | |||
| Value At Risk | (7.84) | |||
| Potential Upside | 6.65 | |||
| Skewness | (0.06) | |||
| Kurtosis | 0.4017 |
Consider Sight Sciences' intraday indicators
Sight Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sight Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sight Sciences Corporate Filings
F4 | 21st of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 5th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Sight Stock media impact
Far too much social signal, news, headlines, and media speculation about Sight Sciences that are available to investors today. That information is available publicly through Sight media outlets and privately through word of mouth or via Sight internal channels. However, regardless of the origin, that massive amount of Sight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sight Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sight Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sight Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sight Sciences alpha.
Sight Sciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Sight Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sight Sciences Corporate Management
| MBA BS | VP Operations | Profile | |
| Stacie Rodgers | VP HR | Profile | |
| John Liu | VP Access | Profile | |
| Stephen JD | Secretary | Profile | |
| Reay MD | Chief Officer | Profile | |
| Sam Park | Chief Officer | Profile | |
| John Ordway | VP Operations | Profile |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.